Perfromance Wealth Partners LLC Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Perfromance Wealth Partners LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 390 shares of the medical equipment provider’s stock, valued at approximately $204,000.

Other large investors have also modified their holdings of the company. Godsey & Gibb Inc. boosted its holdings in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $36,000. Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $38,000. Finally, DT Investment Partners LLC boosted its holdings in shares of Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after buying an additional 36 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In other news, insider Jamie Samath sold 269 shares of the company’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the transaction, the insider now directly owns 8,757 shares in the company, valued at approximately $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 43,509 shares of company stock valued at $22,602,212 over the last 90 days. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $604.12 on Wednesday. The firm has a 50 day simple moving average of $541.80 and a 200-day simple moving average of $500.76. The firm has a market cap of $215.18 billion, a PE ratio of 97.13, a P/E/G ratio of 5.04 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $362.14 and a 1-year high of $606.27.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on ISRG shares. Citigroup increased their price target on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Raymond James lifted their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Leerink Partners lifted their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Finally, Robert W. Baird lifted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $554.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.